United States · FDA National Drug Code directory
Victoza
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0169-4060_0d10d10e-0fe0-47ee-b9da-628e34907e98
- Product NDC
- 0169-4060
- Form
- INJECTION
- Composition / generic term
- liraglutide
- Labeler
- Novo Nordisk
- Marketing category
- NDA
- Marketing start / end (source format)
- 20100125
- Source listing expiry
- 20261231
Source-listed ingredients
- LIRAGLUTIDE — 6 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 SYRINGE, PLASTIC in 1 CARTON (0169-4060-12) / 3 mL in 1 SYRINGE, PLASTIC · 0169-4060-12
- 3 SYRINGE, PLASTIC in 1 CARTON (0169-4060-13) / 3 mL in 1 SYRINGE, PLASTIC · 0169-4060-13
- 1 SYRINGE, PLASTIC in 1 CARTON (0169-4060-90) / 3 mL in 1 SYRINGE, PLASTIC · 0169-4060-90
- 1 SYRINGE, PLASTIC in 1 CARTON (0169-4060-99) / 3 mL in 1 SYRINGE, PLASTIC · 0169-4060-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →